Home › Business › Pharmaceuticals News
July 2, 2014
Pfizer Inc. has a new member of its board of directors: James C. Smith, president and chief executive of Thomson Reuters. The 54-year-old has been appointed to the Corporate Governance and Science and Technology committees of Pfizer's...
June 19, 2014
Groton – A Pfizer facility off Eastern Point Road was evacuated on Thursday following a report that two containers inside the building had built up pressure.
June 17, 2014
Pfizer Inc. opened its new research-and-development hub at Kendall Square in Cambridge, Mass., on Monday.
June 14, 2014
Rod MacKenzie, site leader at Pfizer Inc.'s Groton campus, was elected last week to the board of the bioscience network Connecticut United for Research Excellence.
June 8, 2014
PowerMatch isn’t a dating service; it’s a new way of business networking held late last month in new London, where 14 entrepreneurs met to find out more about others in the region.
June 5, 2014
Twenty-three Brazilian interns will be working at Pfizer Inc. campuses across the country, including in Groton, as part of a program to introduce them to working scientists.
Undergraduate students will spend eight to 12 weeks working next...
May 31, 2014
The Food and Drug Administration on Friday approved the first generic versions of Pfizer's anti-inflammatory painkiller Celebrex.
May 28, 2014
The tax rate in Groton would fall from 20.72 mills to 20.13 mills if a decision made Tuesday night is approved next week.
May 24, 2014
Mystic - U.S. Rep. Joe Courtney said Friday that Pfizer Inc.'s proposed acquisition of rival AstraZeneca partly to take advantage of more favorable tax laws overseas has reopened the debate in Congress about federal tax...
May 23, 2014
U.S. Rep. Joe Courtney said today that pharmaceutical giant Pfizer Inc.’s proposed acquisition of rival AstraZeneca largely to take advantage of more favorable tax laws overseas has reopened the debate in Congress about tax reform.
May 19, 2014
The board of AstraZeneca has rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that has caused a sharp slide in the U.K. company's share price as many investors think it effectively brings an end to the...
May 16, 2014
Drug-resistant bacteria have become a "near critical situation," according to a St. Louis College of Pharmacy expert interviewed by reporter Mark Koba on CNBC.
Ryan Moenster, associate professor of pharmacy practice at the college, said the...
May 12, 2014
Pfizer Inc. has sought to allay concerns over its proposed $106 billion takeover offer of AstraZeneca, insisting that its promises will be legally binding.